A Diversified Portfolio of Technologies Spanning Three Species

There are 2.5 million tons of salmonids harvested per year, and parasites are a major problem in aquaculture. The target market for the swine vaccines and swine probiotics represents subsegments of 1.3 billion pigs farmed annually in the world. The target market for avian vaccines is a subsegment of 62 billion broilers farmed annually.

Parasiticide for aquaculture
Salmonids

Prince Edward Island

Biological swine feed additive
Swine

Saint-Hyacinthe, Québec

Swine vaccine
Swine

Saint-Hyacinthe, Québec

Avian vaccine
Poultry

Laval, Québec

EVAH is developing four Canadian technologies that each requires a different field of expertise but a common knowledge of the animal health sector and share a goal: developing alternatives to antibiotics and drug resistance

A new drug for salmonid farms. (Prince Edward Island)

Live microbes encapsulated in feed to improve piglet gut health and weight gain performance with an interesting efficacy profile compared to probiotics currently on the market. (Saint-Hyacinthe, Québec)

A broadly protective vaccine to prevent a serious infection in pigs for which there is a pressing need. (Saint-Hyacinthe, Québec)

A genetically stable oral/aerosol vaccine against colibacillosis in poultry to prevent diseases from different E. coli serotypes. (Laval, Québec)